Commitment COM-142
Post-approval commitment for EMA-2023-0042. Category: Risk Management. Priority: low.
Commitment ID
COM-142
Application
Authority
European Medicines Agency
Category
Risk Management
Priority
low
Status
Blocked
Due Date
2025-07-27
Completed At
—
Owner
Sarah Chen
Created
2022-10-10
Description
Provide carcinogenicity study report for 2-year rat study
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.